Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2467359rdf:typepubmed:Citationlld:pubmed
pubmed-article:2467359lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:2467359lifeskim:mentionsumls-concept:C0596208lld:lifeskim
pubmed-article:2467359lifeskim:mentionsumls-concept:C0026969lld:lifeskim
pubmed-article:2467359lifeskim:mentionsumls-concept:C0028944lld:lifeskim
pubmed-article:2467359lifeskim:mentionsumls-concept:C0011304lld:lifeskim
pubmed-article:2467359lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:2467359lifeskim:mentionsumls-concept:C0017968lld:lifeskim
pubmed-article:2467359lifeskim:mentionsumls-concept:C1417228lld:lifeskim
pubmed-article:2467359lifeskim:mentionsumls-concept:C0332621lld:lifeskim
pubmed-article:2467359lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:2467359pubmed:issue1lld:pubmed
pubmed-article:2467359pubmed:dateCreated1989-5-5lld:pubmed
pubmed-article:2467359pubmed:abstractTextPrevious work has shown that aggregate cultures prepared from fetal rat telencephalon and grown in a chemically defined medium offer a useful model to study developmental processes such as myelin synthesis. Since compact myelin is formed in these cultures, we investigated the possibility to use this culture system to study demyelinating mechanisms. In particular, we examined the effect of a monoclonal antibody (8-18C5) directed against the myelin/oligodendrocyte glycoprotein (MOG). We found that addition of anti-MOG antibodies and complement to aggregate cultures led to a highly significant decrease in myelin basic protein (MBP) content and 2',3'-cyclic nucleotide 3'-phosphohydrolase (CNP) specific activity. These results indicate that, in our culture system, anti-MOG antibodies have a strong demyelinating effect.lld:pubmed
pubmed-article:2467359pubmed:languageenglld:pubmed
pubmed-article:2467359pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2467359pubmed:citationSubsetIMlld:pubmed
pubmed-article:2467359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2467359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2467359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2467359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2467359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2467359pubmed:statusMEDLINElld:pubmed
pubmed-article:2467359pubmed:issn0258-7661lld:pubmed
pubmed-article:2467359pubmed:authorpubmed-author:HoneggerPPlld:pubmed
pubmed-article:2467359pubmed:authorpubmed-author:MatthieuJ MJMlld:pubmed
pubmed-article:2467359pubmed:authorpubmed-author:LassmannHHlld:pubmed
pubmed-article:2467359pubmed:issnTypePrintlld:pubmed
pubmed-article:2467359pubmed:volume140lld:pubmed
pubmed-article:2467359pubmed:ownerNLMlld:pubmed
pubmed-article:2467359pubmed:authorsCompleteYlld:pubmed
pubmed-article:2467359pubmed:pagination10-3lld:pubmed
pubmed-article:2467359pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:meshHeadingpubmed-meshheading:2467359-...lld:pubmed
pubmed-article:2467359pubmed:year1989lld:pubmed
pubmed-article:2467359pubmed:articleTitleDemyelination in brain cell aggregate cultures, induced by a monoclonal antibody against the myelin/oligodendrocyte glycoprotein (MOG).lld:pubmed
pubmed-article:2467359pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2467359lld:pubmed